ArticleThoracic research and practice2026
Translation, Cultural Adaptation, and Validation of the Turkish Version of the St George's Respiratory Questionnaire for Idiopathic Pulmonary Fibrosis (SGRQ-I).
Article in Thoracic research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Assessment and Outcomes Across Respiratory Diseases.Thoracic research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIdiopathic pulmonary fibrosis (IPF) substantially impairs health-related quality of life (HRQoL). The IPF-specific St George's Respiratory Questionnaire (SGRQ-I) is not available in Turkish. This study aimed to translate, culturally adapt, and validate the SGRQ-I for Turkish-speaking patients with IPF. MATERIAL AND
methodsFollowing international guidelines, the SGRQ-I underwent forward translation, reconciliation, back translation, developer review, and cognitive debriefing. Adult patients with IPF were consecutively recruited. Validity was assessed against the Turkish SGRQ and by examining associations with forced vital capacity (FVC), diffusing capacity for carbon monoxide (DLCO), the six-minute walk test (6MWT), gender-age-physiology (GAP) stage, modified Medical Research Council (mMRC) grade, and long-term oxygen therapy (LTOT) status. Test-retest reliability was assessed over seven days in clinically stable patients.
resultsOne hundred eighty patients were included (mean age 66.3±10.0 years; 36% male). Agreement with the SGRQ was excellent for the activities, impact, and total scores [intraclass correlation coefficients (ICC) >0.90] and moderate for the symptoms score. The SGRQ-I total score was significantly correlated with FVC% (r = -0.476), DLCO% (r = -0.406), and 6MWT distance (r = -0.462, all
conclusionThe Turkish SGRQ-I is a valid and reliable instrument for assessing HRQoL in IPF, supporting its use in clinical practice and multinational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.